McCulley J P
Int Ophthalmol Clin. 1984 Summer;24(2):65-77. doi: 10.1097/00004397-198424020-00009.
Most patients with chronic blepharoconjunctivitis will fall into one of the four seborrheic groups or the primary meibomianitis group. With all of these, there appears to be a predisposition to develop an abnormality in sebaceous glands, as manifested by the fact that such patients have clinically diagnosable seborrheic dermatitis or acne rosacea. These patients tend to develop an abnormality of either the anterior portion of the eyelid with involvement of the gland of Zeis or the posterior portion of the eyelid with involvement of the meibomian glands. Patients in the staphylococcal group are typically younger, a higher percentage are female, and they have a history of symptoms for a relatively shorter period of time. It is only in this latter group that one can hope for a cure with therapy, whereas in the other groups one must aim for control of the disease process. The diagnosis of the various types of blepharoconjunctivitis is important not only because it directs therapy, but also because it gives both the physician and patient an idea about the prognosis. Laboratory evaluation in these patients appears to be of limited value; only in the staphylococcal and mixed seborrheic-staphylococcal group is a pathogen found in the form of S. aureus. The other organism that may contribute directly to disease is S. epidermidis. The antibiotic susceptibility patterns of these two organisms are fairly consistent, and so it is not necessary to culture them to determine antibiotic sensitivities: The majority are sensitive to both bacitracin and erythromycin ointments, as well as the aminoglycosides. Attempts to identify Demodex or to obtain conjunctival scrapings for cytology have not proved helpful. Therefore, the diagnosis is a clinical one and, from a practical standpoint, laboratory evaluation is not required for either diagnosis or management. Therapy for each case of chronic blepharoconjunctivitis must be tailored to the individual and based on the type and severity of blepharoconjunctivitis present. The mainstays in therapy are mechanical and hygienic (i.e., warm compresses and eyelid scrubs ). The use of topical antibiotics must be based on the sensitivities of the likely pathogens (i.e., S. aureus and S. epidermidis). Therefore, while sulfonamides would not appear to be appropriate therapy, bacitracin, erythromycin, or the aminoglycosides are effective antibiotics. The therapy is topical, with the exception of the rare and more severe case of seborrheic blepharoconjunctivitis with secondary meibomianitis and all cases of primary meibomianitis (meibomian keratoconjunctivitis).(ABSTRACT TRUNCATED AT 400 WORDS)
大多数慢性睑结膜炎患者将属于四种脂溢性类型之一或原发性睑板腺炎组。对于所有这些类型,似乎都有一种皮脂腺发育异常的倾向,表现为这些患者临床上可诊断为脂溢性皮炎或酒渣鼻。这些患者往往会出现睑缘前部累及蔡司腺或睑缘后部累及睑板腺的异常。葡萄球菌组的患者通常较年轻,女性比例较高,且症状持续时间相对较短。只有在后者这一组中,人们才有望通过治疗治愈,而在其他组中,必须以控制疾病进程为目标。各种类型睑结膜炎的诊断很重要,不仅因为它指导治疗,还因为它能让医生和患者了解预后情况。对这些患者进行实验室评估似乎价值有限;只有在葡萄球菌组和脂溢性 - 葡萄球菌混合组中能发现金黄色葡萄球菌形式的病原体。另一种可能直接导致疾病的微生物是表皮葡萄球菌。这两种微生物的抗生素敏感性模式相当一致,因此没有必要培养它们来确定抗生素敏感性:大多数对杆菌肽、红霉素眼膏以及氨基糖苷类药物敏感。试图识别蠕形螨或获取结膜刮片进行细胞学检查并无帮助。因此,诊断是临床诊断,从实际角度来看,诊断或管理都不需要实验室评估。每例慢性睑结膜炎的治疗必须因人而异,并基于所患睑结膜炎的类型和严重程度。治疗的主要方法是机械和卫生方面的(即热敷和眼睑擦洗)。局部抗生素的使用必须基于可能病原体(即金黄色葡萄球菌和表皮葡萄球菌)的敏感性。因此,虽然磺胺类药物似乎不是合适的治疗方法,但杆菌肽、红霉素或氨基糖苷类药物是有效的抗生素。除了罕见且更严重的伴有继发性睑板腺炎的脂溢性睑结膜炎病例以及所有原发性睑板腺炎(睑板角膜结膜炎)病例外,治疗都是局部性的。